# OnCo record teclison (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/teclison/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "teclison" ;
  schema:name "Teclison"@en ;
  schema:alternateName "Teclison Ltd."@en ;
  schema:description "Teclison is a US-based biotechnology company that leads 3 cancer trials in OnCo, testing trans-arterial tirapazamine embolisation (TATE) in hepatocellular carcinoma, neuroendocrine tumours and colorectal cancer."@en ;
  schema:url <https://onco.cc/companies/teclison/>, <https://www.teclison.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.teclison.com/>, <https://clinicaltrials.gov/search?lead=Teclison%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/regorafenib/> ;
  onco:trials <https://onco.cc/trials/nct03259867/>, <https://onco.cc/trials/nct02174549/>, <https://onco.cc/trials/nct04701476/> .